Pricing

Log inSign up

Y-mAbs Therapeutics

63 people · 0 jobs
‌

Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.

Industries

Biotechnology

Headquarters

New York, United States

Employees

51-200

Links


Org chart

TG
Thomas Gad
Chairman & CEO
Collapse
Joris Wilms
SVP & COO
SN
Sune Nyland
VP, General Counsel
TS
Tore Søderblom
VP CMC development
Courtney Dugan
Vice President, Head of Investor Relations
Peter Pfreundschuh
Chief Financial Officer
Karen Tornøe
Senior Medical Director
Sharif Koep, Pharm.D.
Global Medical Affairs Director

Board & advisors

Johan Wedell-Wedellsborg
Director
GB
Gérard Ber
Director
AT
Ashutosh Tyagi
Director
JH
James I. Healy
Director
DG
David N. Gill
Director
Laura J. Hamill
Director

Teams

+10

Scientific Research and Development

14 people · 0 jobs

SS
+8

Leadership Team

12 people · 0 jobs

AS
CG
DR
+2

Sales and Account Management

6 people · 0 jobs

+2

Clinical and Medical Operations

6 people · 0 jobs

+1

Marketing and Commercial Strategy

5 people · 0 jobs

Finance and Accounting

2 people · 0 jobs


Offices

  • HQ

    11 people · 0 jobs

    DR
    HD
    +7

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

162 followers

Regeneron

135 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

46 followers

Alexion Pharmaceuticals

45 followers

Explore companies

Company
AboutContactBlog
Product
LearnExploreIterate
Business
SolutionsTrustPricing
Enrich
Browser ExtensionCRM EnrichmentDeveloper Portal
Social
© 2025 Orgio, Inc.
Terms
Privacy
Do not sell my info